Valeant Pharmaceuticals International Inc (NYSE:VRX)

24.27
Delayed Data
As of Jun 22
 -0.45 / -1.82%
Today’s Change
10.94
Today|||52-Week Range
27.79
+16.79%
Year-to-Date

Today’s Trading

Previous close24.72
Today’s open24.29
Day’s range23.82 - 24.47
Volume6,174,842
Average volume (3 months)9,418,480
Market cap$7.3B
Data as of 4:03pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-19.38%
Earnings growth (next 5 years)-0.10%
Revenue growth (last year)-9.82%
P/E ratioNM
Price/Sales0.84
Price/Book1.24

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+1.91+1.94%
CTLTCatalent Inc-0.28-0.67%
ACADACADIA Pharmaceutica...+0.38+2.38%
TAROTaro Pharmaceutical ...-1.36-1.14%
Data as of 4:04pm ET, 06/22/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)$0.76
Annual revenue (last year)$8.7B
Annual profit (last year)$2.4B
Net profit margin27.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive Vice President
Paul S. Herendeen
Corporate headquarters
Laval, Qubec

Forecasts